OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy
Wenpan Li, Yanhao Jiang, Jianqin Lu
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122655-122655
Open Access | Times Cited: 19

Showing 19 citing articles:

Sonodynamic therapy-based nanoplatforms for combating bacterial infections
Pei‐Yao Xu, Ranjith Kumar Kankala, Shi‐Bin Wang, et al.
Ultrasonics Sonochemistry (2023) Vol. 100, pp. 106617-106617
Open Access | Times Cited: 35

Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 19

Harnessing Nanotechnology for Idarubicin Delivery in Cancer Therapy: Current Approaches and Future Perspectives
Fatemeh Safari, Yeganeh Jalalian, Hamidreza Abdouss, et al.
BioNanoScience (2024) Vol. 14, Iss. 4, pp. 4108-4130
Closed Access | Times Cited: 7

Construction and performance evaluation of pH-responsive oxidized hyaluronic acid hollow mesoporous silica nanoparticles
Xu Enyu, Xinbo Liu, Xuelian Chen, et al.
International Journal of Biological Macromolecules (2023) Vol. 257, pp. 128656-128656
Closed Access | Times Cited: 11

Enhancing immunotherapy with tumour-responsive nanomaterials
Stephen W. Linderman, Louis DeRidder, Lucía Sanjurjo, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access

Deciphering a crosstalk between biological cues and multifunctional nanocarriers in lung cancer therapy
Sharon George, Hendry Saju, Tharun Jaikumar, et al.
International Journal of Pharmaceutics (2025), pp. 125395-125395
Closed Access

Nanocarriers for cutting-edge cancer immunotherapies
Joyce Hu, Pooria Mohammadi Arvejeh, S Bone, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer
Wenlu Yan, Yu Li, Yiting Zou, et al.
International Journal of Pharmaceutics (2023) Vol. 648, pp. 123583-123583
Closed Access | Times Cited: 9

Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy
Nayeon Shim, Hanhee Cho, Seong Ik Jeon, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 54, Iss. 1, pp. 13-36
Closed Access | Times Cited: 7

Lipid-based nanoparticles for cancer immunotherapy
Shumin Fan, Huize Han, Zhicheng Yan, et al.
Medical Review (2023) Vol. 3, Iss. 3, pp. 230-269
Open Access | Times Cited: 4

Nanotechnology and Immunetherapy: reduction of hepatotoxicity and anti-antineoplastic efficiency
Irami Araújo-Filho, Amália Cínthia Meneses do Rêgo
JOURNAL OF SURGICAL AND CLINICAL RESEARCH (2024) Vol. 15, Iss. 1, pp. 59-78
Open Access | Times Cited: 1

Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
Tuan Hiep Tran, Thi Thu Phuong Tran
International Immunopharmacology (2024) Vol. 142, pp. 113085-113085
Closed Access | Times Cited: 1

Nanotechnology-Based Strategies for Safe and Effective Immunotherapy
Seungpyo Hong, Juwon Park, Yoo Jin Oh, et al.
Molecules (2024) Vol. 29, Iss. 24, pp. 5855-5855
Open Access | Times Cited: 1

The evolution of immune profiling: will there be a role for nanoparticles?
Olga E. Eremina, Celine Vazquez, Kimberly N. Larson, et al.
Nanoscale Horizons (2024)
Closed Access

Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance
Ting Mei, Ting Ye, Donghua Huang, et al.
Cellular Oncology (2024)
Closed Access

CAR-T cell a potential platform for cancer therapy
Ankit Maurya, Shivani Saraf, Laxmikant Gautam, et al.
Medicine in Novel Technology and Devices (2024), pp. 100348-100348
Open Access

NIR-II responsive Janus nanoparticles amplify immunogenic cell death for enhanced cancer immunotherapy
Beibei Chen, Kangli Guo, HaoRan Wang, et al.
Science China Technological Sciences (2023)
Closed Access

Page 1

Scroll to top